Where does EVOK stock trade?

Evoke Pharma Inc. (EVOK) is listed on NASDAQ.

What sector and industry is EVOK in?

Evoke Pharma Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.

When did Evoke Pharma Inc. go public?

Evoke Pharma Inc. (EVOK) completed its IPO in 2013.

What companies are similar to EVOK?

Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare EVOK side-by-side with any of them on Quantisnow.

How can I track EVOK on Quantisnow?

Quantisnow aggregates Evoke Pharma Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow EVOK to receive live email and push alerts on every new disclosure.

EVOK

NASDAQ

Evoke Pharma Inc.

SectorHealth CareIndustryBiotechnology: Pharmaceutical PreparationsIPO2013

$10.99+0.04 (+0.37%)

Follow Website

News25/Ratings0

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase III clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.

Price$10.99+5.82 (+112.37%)

2025-09-152025-12-16

News · 26 weeks330%

2025-12-072026-05-31

Mix090d

No activity.

Latest news

25 items

EVOK FAQ

6 questions

What does Evoke Pharma Inc. do?
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase III clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana...
Where does EVOK stock trade?
Evoke Pharma Inc. (EVOK) is listed on NASDAQ.
What sector and industry is EVOK in?
Evoke Pharma Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
When did Evoke Pharma Inc. go public?
Evoke Pharma Inc. (EVOK) completed its IPO in 2013.
What companies are similar to EVOK?
Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare EVOK side-by-side with any of them on Quantisnow.
How can I track EVOK on Quantisnow?
Quantisnow aggregates Evoke Pharma Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow EVOK to receive live email and push alerts on every new disclosure.